Integra LifeSciences Allies with TomoTherapy To Provide Image-Guided Stereotactic Radiosurgery

(Plainsboro, NJ, USA) announced that its subsidiary, Integra Radionics, Inc., has entered into a strategic alliance with TomoTherapy, Inc. (Madison, WI, USA). The companies will develop and supply the InterFix radiosurgery kit, a collection of stereotactic radiosurgery components for the TomoTherapy Hi-Art system.

The Hi-Art treatment system is an advanced radiation delivery system for the treatment of cancer, and combines integrated computed tomography (CT) imaging with sophisticated conformal control of target volume irradiation. The new alliance will focus on methods of precise cranial immobilization for radiosurgery with the Hi-Art system. Integra will provide these capabilities through its research and development team, which has developed Radionics CRW stereotactic neurosurgery and Radionics XKnife radio surgery product lines.

Stereotactic radiosurgery is a minimally invasive technique used to deliver a single high dose of radiation to small, well-defined target volumes, while avoiding nearby normal tissue and critical structures. The targeted volumes are primarily brain tumors and vascular malformations.

"We are delighted to be aligned with Integra,” said Del Coufal, vice president of marketing at TomoTherapy. "The addition of Radionics InterFix radiosurgery kits enhances the radiosurgical solution we can offer TomoTherapy customers worldwide.”

"TomoTherapy has developed a unique radiation treatment system,” said Christopher von Jako, general manager of Integra Radionics. "We are excited about the opportunity this alliance allows for us to expand our radiosurgery offering.”

Integra LifeSciences Holdings products are used to treat millions of patients every year, primarily in neurosurgery, extremity reconstruction, orthopedics, and general surgery

TomoTherapy was founded to find the best way to harness the power and precision of intensity-modulated radiation therapy (IMRT) with integrated imaging technology that can provide accuracy at every treatment fraction.


Related Links:
IntegraLifeSciences Holdings
TomoTherapy